The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients
Status:
Withdrawn
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical efficacy of an investigational agent,
P10s-PADRE, a peptide mimotope-based vaccine in subjects with metastatic cancer.